Loading clinical trials...
Loading clinical trials...
Ketone Pharmacokinetic Study in Heart Failure With Reduced Ejection Fraction
The purpose of this study is to test whether an over-the-counter ketone ester drink is well tolerated in people with heart failure on, and not on, a heart failure medication class called SGLT2 inhibitors. The research team is trying to determine the safest dose of Delta G. The study has a single visit. Participants will be served a light breakfast with the study drink, a physical exam will be conducted, and the study team will obtain information about demographics and medical history. The study team will draw blood intravenously up to eight times over the course of the half-day visit.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Duke University
Durham, North Carolina, United States
Start Date
June 2, 2023
Primary Completion Date
January 11, 2024
Completion Date
January 11, 2024
Last Updated
December 27, 2024
20
ACTUAL participants
DeltaG (250 mg/kg)
DIETARY_SUPPLEMENT
DeltaG (500 mg/kg)
DIETARY_SUPPLEMENT
Lead Sponsor
Duke University
Collaborators
NCT07057466
NCT06859970
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions